Responses
EULAR 2014: Scientific Abstracts
Abstracts accepted for publication. Spondyloarthritis - treatment
AB0656 Golimumab versus Pamidronate for the Treatment of Axial Spondyloarthropathy (SPA): A 48-Week Randomized Controlled Trial
Compose a Response to This Article
Other responses
No responses have been published for this article.